Inotiv Inc (NOTV)
4.06
-0.23
(-5.36%)
USD |
NASDAQ |
Apr 26, 10:53
Inotiv Cash from Financing (TTM): -5.433M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -5.433M |
September 30, 2023 | 15.87M |
June 30, 2023 | 30.17M |
March 31, 2023 | 29.84M |
December 31, 2022 | 102.07M |
September 30, 2022 | 203.15M |
June 30, 2022 | 323.74M |
March 31, 2022 | 390.68M |
December 31, 2021 | 318.73M |
September 30, 2021 | 198.83M |
June 30, 2021 | 64.05M |
March 31, 2021 | 1.723M |
December 31, 2020 | 4.663M |
September 30, 2020 | 9.641M |
June 30, 2020 | 12.09M |
March 31, 2020 | 11.75M |
December 31, 2019 | 11.03M |
September 30, 2019 | 6.205M |
June 30, 2019 | 9.155M |
March 31, 2019 | 6.153M |
December 31, 2018 | 4.739M |
September 30, 2018 | 4.926M |
June 30, 2018 | -0.599M |
March 31, 2018 | -0.646M |
December 31, 2017 | 0.073M |
Date | Value |
---|---|
September 30, 2017 | -0.849M |
June 30, 2017 | -0.989M |
March 31, 2017 | -0.753M |
December 31, 2016 | -1.343M |
September 30, 2016 | 0.144M |
June 30, 2016 | 0.413M |
March 31, 2016 | 0.054M |
December 31, 2015 | -0.741M |
September 30, 2015 | -1.213M |
June 30, 2015 | -1.144M |
March 31, 2015 | -0.513M |
December 31, 2014 | -0.084M |
September 30, 2014 | -1.513M |
June 30, 2014 | -0.505M |
March 31, 2014 | -1.627M |
December 31, 2013 | -1.681M |
September 30, 2013 | -1.022M |
June 30, 2013 | -1.916M |
March 31, 2013 | -1.37M |
December 31, 2012 | -1.495M |
September 30, 2012 | -1.164M |
June 30, 2012 | -1.633M |
March 31, 2012 | 2.515M |
December 31, 2011 | 1.831M |
September 30, 2011 | 1.66M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-5.433M
Minimum
Dec 2023
390.68M
Maximum
Mar 2022
91.47M
Average
15.87M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Avid Bioservices Inc | 8.937M |
Macrogenics Inc | 150.36M |
Synlogic Inc | 20.94M |
BioXcel Therapeutics Inc | 26.52M |
IGM Biosciences Inc | 115.07M |